Literature DB >> 23627854

West Nile virus and kidney disease.

Luisa Barzon1, Monia Pacenti, Giorgio Palù.   

Abstract

West Nile virus (WNV), the causative agent of West Nile fever and West Nile neuroinvasive disease in humans, has become endemic in many countries in all continents. Concerns on long-term mobility from WNV have arisen from recent studies that reported chronic kidney disease in patients who recovered from WNV infection, supported by data from animal models that showed prolonged excretion of the virus with urine. The purpose of this review is to summarize and discuss the results of studies in the literature that investigated WNV infection of the kidney in humans and in animal models and WNV excretion with urine, the potential damage to the kidney caused by WNV infection, the risk of WNV disease in kidney transplant recipients, the significance of detecting WNV in urine and its use in the diagnosis of WNV infection, and kidney involvement by other mosquito-borne flaviviruses.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23627854     DOI： 10.1586/eri.13.34

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN： 1478-7210            Impact factor:   5.091


  12 in total

Review 1.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

2.  Isolation of West Nile virus from urine samples of patients with acute infection.

Authors:  Luisa Barzon; Monia Pacenti; Elisa Franchin; Laura Squarzon; Alessandro Sinigaglia; Sebastian Ulbert; Riccardo Cusinato; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

3.  The value of West Nile virus RNA detection by real-time RT-PCR in urine samples from patients with neuroinvasive forms.

Authors:  Mariem Gdoura; Wasfi Fares; Souha Bougatef; Amine Inoubli; Henda Touzi; Nahed Hogga; Imen Ben Dhifallah; Naila Hannachi; Aida Argoubi; Saoussen Kacem; Hela Karray; Nissaf Ben Alaya; Henda Triki
Journal:  Arch Microbiol       Date:  2022-04-03       Impact factor: 2.552

4.  A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.

Authors:  Neal Van Hoeven; Sharvari Waghmare Joshi; Ghislain Ismael Nana; Angela Bosco-Lauth; Christopher Fox; Richard A Bowen; David E Clements; Timothy Martyak; D Elliot Parks; Susan Baldwin; Steven G Reed; Rhea N Coler
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

5.  Acute West Nile Virus Meningoencephalitis Diagnosed Via Metagenomic Deep Sequencing of Cerebrospinal Fluid in a Renal Transplant Patient.

Authors:  M R Wilson; L L Zimmermann; E D Crawford; H A Sample; P R Soni; A N Baker; L M Khan; J L DeRisi
Journal:  Am J Transplant       Date:  2016-10-21       Impact factor: 8.086

6.  Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virus.

Authors:  Babs E Verstrepen; Zahra Fagrouch; Melanie van Heteren; Hester Buitendijk; Tom Haaksma; Niels Beenhakker; Giorgio Palù; Justin M Richner; Michael S Diamond; Willy M Bogers; Luisa Barzon; Stefan Chabierski; Sebastian Ulbert; Ivanela Kondova; Ernst J Verschoor
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17

7.  Large human outbreak of West Nile virus infection in north-eastern Italy in 2012.

Authors:  Luisa Barzon; Monia Pacenti; Elisa Franchin; Silvana Pagni; Enrico Lavezzo; Laura Squarzon; Thomas Martello; Francesca Russo; Loredana Nicoletti; Giovanni Rezza; Concetta Castilletti; Maria Rosaria Capobianchi; Pasquale Salcuni; Margherita Cattai; Riccardo Cusinato; Giorgio Palù
Journal:  Viruses       Date:  2013-11-22       Impact factor: 5.048

Review 8.  Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity.

Authors:  Yaniv Lustig; Danit Sofer; Efrat Dahan Bucris; Ella Mendelson
Journal:  Front Microbiol       Date:  2018-10-11       Impact factor: 5.640

Review 9.  Find the right sample: A study on the versatility of saliva and urine samples for the diagnosis of emerging viruses.

Authors:  Matthias Niedrig; Pranav Patel; Ahmed Abd El Wahed; Regina Schädler; Sergio Yactayo
Journal:  BMC Infect Dis       Date:  2018-12-29       Impact factor: 3.090

10.  An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.

Authors:  Christopher W Woods; Ana M Sanchez; Geeta K Swamy; Micah T McClain; Lynn Harrington; Debra Freeman; Elizabeth A Poore; Dawn K Slifka; Danae E Poer DeRaad; Ian J Amanna; Mark K Slifka; Shu Cai; Venus Shahamatdar; Michael R Wierzbicki; Cyrille Amegashie; Emmanuel B Walter
Journal:  Vaccine       Date:  2019-01-18       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.